Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Intravesical mitomycin C (MMC) and MMC + cytosine arabinoside for non-muscle-invasive bladder cancer: a randomised clinical trial
BJU International ( IF 3.7 ) Pub Date : 2021-08-12 , DOI: 10.1111/bju.15571 Yasuyoshi Miyata 1 , Toshifumi Tsurusaki 2 , Yasushi Hayashida 3 , Yushi Imasato 2 , Kosuke Takehara 4 , Daiyu Aoki 5 , Masaharu Nishikido 6 , Junichi Watanabe 4 , Kensuke Mitsunari 1 , Tomohiro Matsuo 1 , Kojiro Ohba 1 , Keisuke Taniguchi 3 , Hideki Sakai 1 ,
BJU International ( IF 3.7 ) Pub Date : 2021-08-12 , DOI: 10.1111/bju.15571 Yasuyoshi Miyata 1 , Toshifumi Tsurusaki 2 , Yasushi Hayashida 3 , Yushi Imasato 2 , Kosuke Takehara 4 , Daiyu Aoki 5 , Masaharu Nishikido 6 , Junichi Watanabe 4 , Kensuke Mitsunari 1 , Tomohiro Matsuo 1 , Kojiro Ohba 1 , Keisuke Taniguchi 3 , Hideki Sakai 1 ,
Affiliation
To compare the urinary pH, recurrence-free survival (RFS), and safety of adjuvant intravesical therapy in patients with non-muscle-invasive bladder cancer (NMIBC) receiving mitomycin C (MMC) therapy and MMC + cytosine arabinoside (Ara-C) therapy.
中文翻译：
膀胱内丝裂霉素 C (MMC) 和 MMC + 胞嘧啶阿糖苷治疗非肌肉浸润性膀胱癌：一项随机临床试验
比较接受丝裂霉素 C (MMC) 和 MMC + 胞嘧啶阿拉伯糖苷 (Ara-C) 治疗的非肌层浸润性膀胱癌 (NMIBC) 患者的尿液 pH 值、无复发生存期 (RFS) 和膀胱内辅助治疗的安全性治疗。
更新日期：2021-08-12
中文翻译：
膀胱内丝裂霉素 C (MMC) 和 MMC + 胞嘧啶阿糖苷治疗非肌肉浸润性膀胱癌：一项随机临床试验
比较接受丝裂霉素 C (MMC) 和 MMC + 胞嘧啶阿拉伯糖苷 (Ara-C) 治疗的非肌层浸润性膀胱癌 (NMIBC) 患者的尿液 pH 值、无复发生存期 (RFS) 和膀胱内辅助治疗的安全性治疗。
京公网安备 11010802027423号